v3.7.0.1
CONDENSED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating expenses:    
Research and development $ 1,338,604 $ 372,426
General and administrative 1,557,341 1,939,148
Depreciation 3,069 2,908
Total operating expenses 2,899,014 2,314,482
Loss from operations (2,899,014) (2,314,482)
Other income (expense):    
Loss on change in fair value of derivatives (373,611) (268,425)
Loss before income taxes (3,272,625) (2,582,907)
Income taxes (benefit) 0 0
Net loss (3,272,625) (2,582,907)
Preferred stock dividend (23,745) (32,244)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (3,296,370) $ (2,615,151)
Net loss per common share, basic and diluted (in Dollars per share) $ (0.14) $ (0.15)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 23,051,872 17,074,329

Source